Edition:
United Kingdom

Clearside Biomedical Inc (CLSD.OQ)

CLSD.OQ on NASDAQ Stock Exchange Global Market

0.70USD
23 Aug 2019
Change (% chg)

$-0.07 (-9.45%)
Prev Close
$0.78
Open
$0.75
Day's High
$0.80
Day's Low
$0.70
Volume
260,359
Avg. Vol
113,378
52-wk High
$7.06
52-wk Low
$0.68

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.05 -0.451
FY 2018 Dec '18 0.03 -0.675
Sep '18 0.00 -0.745
Jun '18 0.00 -0.647
Mar '18 0.00 -0.619
FY 2017 Dec '17 0.05 -0.651
Sep '17 0.16 -0.724
Jun '17 0.13 -0.544
Mar '17 0.00 -0.411
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 8 0.44 3.50 0.00 0.05
Quarter Ending Dec-19 8 0.93 7.41 0.00 0.05
Year Ending Dec-19 8 1.40 10.90 0.00 4.31
Year Ending Dec-20 8 16.55 27.76 5.80 23.80
Earnings (per share)
Quarter Ending Sep-19 8 -0.35 -0.23 -0.46 -0.69
Quarter Ending Dec-19 8 -0.34 -0.23 -0.49 -0.68
Year Ending Dec-19 8 -1.51 -1.17 -1.78 -2.19
Year Ending Dec-20 8 -1.15 -0.69 -1.58 -1.83
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 98.31 33.85
P/E High - Last 5 Yrs. -- 169.52 54.29
P/E Low - Last 5 Yrs. -- 53.54 28.22
Beta -- 1.29 0.99
Price to Sales (TTM) 556.41 42.65 7.90
Price to Book (MRQ) 2.54 12.25 4.38
Price to Tangible Book (MRQ) 2.59 17.14 5.07
Price to Cash Flow (TTM) -- 64.56 23.70
% Owned Institutions 29.00 3.24 1.78

Dividends

  Company industry sector
Dividend Yield -- 0.11 1.67
Dividend Yield - 5 Year Avg -- 0.05 1.37
Dividend 5 Year Growth Rate -- 0.86 6.82
Payout Ratio(TTM) -- 2.55 46.67

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 53.93 14.65
Sales (TTM) vs TTM 1 Yr. Ago -77.94 51.52 8.45
Sales - 5 Yr. Growth Rate -- 33.42 9.43
EPS (MRQ) vs Qtr. 1 Yr. Ago 27.15 -8.31 19.40
EPS (TTM) vs TTM 1 Yr. Ago 0.74 -- --
EPS - 5 Yr. Growth Rate -- 22.74 7.15
Capital Spending - 5 Yr. Growth Rate 6.91 26.66 8.01

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.76 2.52
Current Ratio (MRQ) 3.04 3.87 3.52
LT Debt to Equity (MRQ) 53.74 7.63 12.61
Total Debt to Equity (MRQ) 62.37 20.26 17.64
Interest Coverage (TTM) -- 30.21 14.93

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 21.69 50.25
Gross Margin - 5 Yr. Avg. -- 58.96 51.36
EBITD Margin (TTM) -108,804.00 -- --
EBITD - 5 Yr. Avg -21,582.35 -12.49 16.42
Operating Margin (TTM) -109,064.00 -124.67 -6.97
Operating Margin - 5 Yr. Avg. -21,641.45 -28.74 11.87
Pre-Tax Margin (TTM) -108,820.00 -126.48 -7.30
Pre-Tax Margin - 5 Yr. Avg. -21,843.91 -34.06 15.72
Net Profit Margin (TTM) -108,820.00 -132.21 -11.11
Net Profit Margin - 5 Yr. Avg. -21,843.91 -38.92 11.11
Effective Tax Rate (TTM) -- 17.21 20.61
Effective Tax Rate - 5 Yr. Avg. -- 18.84 24.51

Efficiency

  Company industry sector
Revenue/Employee (TTM) 1,500 10,400,894 870,638,159
Net Income/Employee (TTM) -1,632,300 2,349,448 101,855,832
Receivable Turnover (TTM) -- 12.32 5.88
Inventory Turnover (TTM) -- 2.26 3.66
Asset Turnover (TTM) 0.00 0.32 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -114.95 6.26 10.25
Return on Assets - 5 Yr. Avg. -108.74 6.14 11.17
Return on Investment (TTM) -140.13 7.52 12.69
Return on Investment - 5 Yr. Avg. -132.40 7.98 14.15
Return on Equity (TTM) -159.99 7.94 17.13
Return on Equity - 5 Yr. Avg. -447.96 8.90 15.53
  1 Year 3 Year 5 Year
Sales % -91.30 -- --
EPS (TTM) % -15.65 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Clearside Biomedical Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 16.28 13.05 89 4
13 Week -10.32 -12.87 52 7
26 Week -2.59 -14.21 53 20
52 Week -87.39 -88.17 6 12
YTD 5.61 -12.51 52 9
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 29.00%
# of Holders: 82
Total Shares Held: 10,901,348
3 Mo. Net Change: 16,245
# New Positions: 5
# Closed Positions: 0
# Increased Positions: 5
# Reduced Positions: 2
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.